VulnTideExploited vulnerabilities, by vendor. Data as of 28 Oct 2026.
Known exploitedIn CISA's KEV catalog since 19 May 2025Ransomware use: unknown
ZKTeco BioTime

CVE-2023-38950: ZKTeco BioTime Path Traversal Vulnerability

Is it exploited?

Yes. CISA added it to the Known Exploited Vulnerabilities catalog on 19 May 2025, 655 days after the CVE record was published.

How likely is exploitation in the next 30 days?
92.5%

EPSS score, percentile 99.8 of all scored records

How severe?
7.5 High

CVSS v3.1 base score, from CISA's enrichment of the record

What should I do?

Required action (CISA), due 9 Jun 2025: Apply mitigations per vendor instructions, follow applicable BOD 22-01 guidance for cloud services, or discontinue use of the product if mitigations are unavailable.

The CVE record links no vendor advisory, patch or mitigation.

Which versions are affected?

Not stated. The CVE record gives vendor and product as “n/a” and the version as “unspecified”.

Source: CISA Known Exploited Vulnerabilities (KEV) catalog, 2026.10.28, as of 28 Oct 2026; FIRST Exploit Prediction Scoring System (EPSS), v2026.06.15, as of 28 Oct 2026; CVE List V5 (CVE Program), cve_2026-10-28_0000Z, as of 28 Oct 2026. About the data.

What to do

Required action, set by CISA

Apply mitigations per vendor instructions, follow applicable BOD 22-01 guidance for cloud services, or discontinue use of the product if mitigations are unavailable.

CISA due date for this action: 9 June 2025.

Advisories and patches

The CVE record links no vendor advisory, patch or mitigation.

Linked from CISA's catalog entry

Affected products and versions

The CVE record does not name affected products or versions: vendor and product are “n/a” and the version is “unspecified”.

Source: CVE List V5 (CVE Program), cve_2026-10-28_0000Z, as of 28 Oct 2026. About the data.

About this vulnerability

ZKTeco BioTime contains a path traversal vulnerability in the iclock API that allows an unauthenticated attacker to read arbitrary files via supplying a crafted payload.

Summary: CISA's KEV catalog, as of 28 Oct 2026.

  • CISA added CVE-2023-38950 to its Known Exploited Vulnerabilities (KEV) catalog on 19 May 2025.
  • CISA's ransomware flag for this entry is "Unknown": no evidence of ransomware use in the catalog, which is not proof of none.
  • The due date CISA sets for the required action is 9 Jun 2025.
  • The CVE record was published on 3 Aug 2023, 655 days before it was added to KEV.
  • The CVE record carries a CVSS v3.1 base score of 7.5 (High), taken from CISA's enrichment of the record.
  • FIRST's EPSS model puts the probability of exploitation in the next 30 days at 92.5% (percentile 99.8), as of 28 Oct 2026.
  • CISA's SSVC assessment in the CVE record: exploitation active, automatable yes, technical impact partial.

Source: CISA Known Exploited Vulnerabilities (KEV) catalog, 2026.10.28, as of 28 Oct 2026; CVE List V5 (CVE Program), cve_2026-10-28_0000Z, as of 28 Oct 2026; FIRST Exploit Prediction Scoring System (EPSS), v2026.06.15, as of 28 Oct 2026. About the data.

Description

A path traversal vulnerability in the iclock API of ZKTeco BioTime v8.5.5 allows unauthenticated attackers to read arbitrary files via supplying a crafted payload. This vulnerability was fixed in version 9.0.120240617.19506 of ZKBioTime.

Source: CVE List V5 (CVE Program), cve_2026-10-28_0000Z, as of 28 Oct 2026. About the data.

Weakness

  • CWE-22: Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')

CWE and CAPEC are maintained by MITRE; the entries are those named in the CVE record and the KEV entry.

Timeline

DateEvent
3 Aug 2023CVE record published
19 May 2025Added to CISA KEV
9 Jun 2025CISA due date for the required action
9 Jul 2026CVE record last updated

References